宮頸上皮內(nèi)瘤變術(shù)后復(fù)發(fā)及殘留高危因素分析
[Abstract]:Cervical intraepithelial neoplasia (CIN) is a group of cervical lesions closely related to the occurrence of invasive cervical cancer, which mainly occurs in women aged 25-35. Most of the low-grade CIns can be regressive, but the high-grade CIns have the possibility of carcinogenesis, can develop into invasive cancer, and are considered as precancerous lesions. The pathological grading of cervical intraepithelial neoplasia is divided into three grades: CIN1, CIN2, and CIN3, in which CIN3 includes severe atypical hyperplasia and carcinoma in situ, reflecting the continuous process from cervical lesions to cervical cancer, which takes about 10 years to develop from CIN to cervical cancer. Therefore, early diagnosis and early treatment of CIN can reduce the incidence of cervical cancer. Clinically, the diagnosis of cervical cancer should follow the "three steps" principle: cervical cytology, colposcopy and pathological examination, pathological examination is the golden standard for the diagnosis of cervical cancer. Cryotherapy and so on, but the traditional method trauma is bigger, the patient's postoperative complication rate is higher and easy to recur, currently the clinical application of cervical loop electrosurgical excision (LEEP) and cold knife conization (CKC) to treat cervical intraepithelial neoplasia, has a significant therapeutic effect, but there are still patients with recurrence after surgery. ASCCP's new guidelines for cervical cancer screening recommend that for histologically diagnosed CIN2 and CIN3, surface destruction therapy is not recommended, but diagnostic cervical conization is recommended, but 1-25% of patients fail to treat after surgery. Failure of CIN treatment may lead to recurrence after CIN surgery, but may also develop into invasive cancer. Therefore, analysis of cervical conization The high risk factors of recurrence and residual after resection can be distinguished from the high risk patients of recurrence after CIN treatment. These patients should be followed up closely to find the lesions and further treatment in time to achieve the purpose of early prevention of recurrence of CIN, so as to effectively control the recurrence and progress of the disease. Objective: To evaluate the clinical efficacy of LEEP and CKC in the treatment of CI N, and to compare the intraoperative bleeding volume, postoperative complications and postoperative recurrence rate of the two kinds of surgery. The clinical and pathological data of patients with CIN were analyzed to study the relapse of CIN and its relationship with age, pregnancy, parity, menopause, preoperative pathological grading, CIN 3 lesion number (> 3), cervical erosion-like changes, surgical methods, postoperative pathological margin, gland involvement, preoperative and postoperative 6. Correlation among monthly HPV infection, scc, family history of tumor, smoking and alcohol consumption was studied. High risk factors associated with postoperative recurrence and residue of CIN patients were identified by univariate and multivariate analysis. High risk patients who were prone to recurrence after CIN treatment were identified and followed up closely. If further treatment was found, the patients would be treated promptly. Materials and methods: the clinical and pathological data of 256 patients with CIN admitted to Dalian Medical University from June 2012 to December 2014 were collected and analyzed by SPSS 19.0 statistical software. t test, Pearson x2 test and logistic regression analysis were used to review the data. Sexually analyze the clinical efficacy of LEEP and CKC in the treatment of cin, and analyze the difference of the cure rate and recurrence rate of CIN between the two surgical methods. Univariate and multivariate analysis was used to analyze the postoperative recurrence of cin, residual and age, pregnancy, parity, menopause, preoperative pathological grading, CIN 3 lesion points, cervical erosion-like changes, surgery. Results: A total of 256 patients with CIN were enrolled in this study. 100 of them underwent LEEP in the outpatient department of our hospital, 156 underwent CKC in the operating room of our hospital. A total of 20 patients were followed up for 24 months. Postoperative recurrence was found in 14 cases (14%) in LEEP group, 6 cases (3.85%) in CKC group, and the recurrence rate in LEEP group was significantly higher than that in CKC group (or = 4.070, 95% CI = 1.509-10.979), so the therapeutic effect of CKC was significantly higher than that in LEEP group. Pathological grading, CIN 3 lesion points (> 3 points), surgical methods, positive incision margin, 6 months after surgery, HPV persistent positive significantly correlated (x2 values were 7.024; 7.449; 12.502; 5.769; 8.723; 15.00; 40.693), the difference was statistically significant (p < 0.05); but with the patient's age, pregnancy, cervical erosion-like changes, preoperative HPV infection, SCC value, tumor home There was no correlation between family history, smoking and drinking history and postoperative gland involvement (p0.05). multivariate logistic regression analysis showed that postmenopausal, CIN3 lesion number (> 3), positive incision margin and persistent positive HPV 6 months after operation were independent risk factors for postoperative recurrence of CIN (or value was 22.85, respectively). Conclusion: For the treatment of cin, the curative effect of CKC is better than that of leep, and the recurrence rate of CKC is lower than that of leep. The recurrence rate of CKC is lower than that of leep. cin. The recurrence rate of CKC is lower than that of leep. The persistent positive rate of HPV was significantly correlated with the degree of cervical erosion, SCC, family history of cancer, smoking and alcohol consumption. Positive incision margin, CIN3 lesion number (>3) and persistent positive rate of HPV 6 months after operation were independent risk factors for recurrence of CIN.
【學(xué)位授予單位】:大連醫(yī)科大學(xué)
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2017
【分類號(hào)】:R737.33
【參考文獻(xiàn)】
相關(guān)期刊論文 前10條
1 董國(guó)麗;;宮頸糜爛程度與宮頸上皮內(nèi)瘤變和宮頸癌變的關(guān)系研究[J];世界最新醫(yī)學(xué)信息文摘;2016年73期
2 周萍;羅小婉;符麗華;;兩種宮頸錐切術(shù)治療宮頸上皮內(nèi)瘤變Ⅲ級(jí)的臨床分析[J];中國(guó)實(shí)用醫(yī)刊;2016年13期
3 王斌;張?jiān)绿?李瓊珍;;鱗癌抗原在宮頸癌前病變及早期宮頸癌治療中的價(jià)值[J];臨床和實(shí)驗(yàn)醫(yī)學(xué)雜志;2016年07期
4 陳春光;;宮頸糜爛與宮頸癌及宮頸上皮內(nèi)瘤變的關(guān)系初探[J];齊齊哈爾醫(yī)學(xué)院學(xué)報(bào);2016年08期
5 龍馨;楊君;秦婷婷;周德平;;宮頸上皮內(nèi)瘤變LEEP術(shù)后殘留或復(fù)發(fā)相關(guān)因素分析[J];重慶醫(yī)學(xué);2016年03期
6 李暉;王仙榮;;HPV檢測(cè)在宮頸上皮內(nèi)瘤變術(shù)后復(fù)發(fā)預(yù)測(cè)上的意義探究[J];中國(guó)性科學(xué);2016年01期
7 張丹;張玉揚(yáng);;影響CIN患者行LEEP術(shù)后預(yù)后的相關(guān)因素分析[J];中國(guó)現(xiàn)代醫(yī)生;2016年04期
8 盧丹;宋晶哲;尹香花;周菲;蔣志琴;;宮頸電切術(shù)治療宮頸上皮內(nèi)瘤變465例臨床分析[J];實(shí)用臨床醫(yī)藥雜志;2016年01期
9 曾燕;盧愛妮;廖予妹;;宮頸上皮內(nèi)瘤變錐切術(shù)后復(fù)發(fā)的相關(guān)預(yù)測(cè)因素[J];實(shí)用醫(yī)學(xué)雜志;2015年04期
10 鄧遠(yuǎn)征;;宮頸上皮內(nèi)瘤變術(shù)后復(fù)發(fā)的高危因素Meta分析[J];中國(guó)實(shí)用醫(yī)藥;2014年36期
,本文編號(hào):2244913
本文鏈接:http://sikaile.net/yixuelunwen/fuchankeerkelunwen/2244913.html